3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30654495 | Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis. | 2019 Jan 16 | 1 |
| 2 | 28052855 | The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies. | 2017 Mar | 1 |
| 3 | 26700136 | Nonclinical Safety Assessment of SYN-004: An Oral β-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics. | 2016 May | 1 |